As announced on June 26, 2021, CELLINK AB (publ) (“CELLINK”) entered into an agreement to acquire Discover Echo Inc. (“Discover Echo”), an innovative and revolutionary American company focusing on development, manufacturing, and sales of patented and unique hybrid microscopes that easily transform between Upright and Inverted configurations, merging the capabilities of multiple instruments into one. […]
— Accelerates Conversion from Microarray to Genotyping by Sequencing– — Expands NGS Capabilities into New Markets — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the acquisition of iGenomX, a company offering multiplex library […]
Combined with Cytiva’s existing manufacturing in Logan, Utah, Intermountain will boost global production of buffers and liquid cell culture media to Cytiva’s customers Responds to increased demand for products that are used in emerging modalities such as gene therapy, and are currently in high demand for the manufacture of COVID-19 vaccines and therapies Cytiva intends […]
Transaction will expand BioIVT’s in vitro diagnostic, cell and gene therapy support capabilities Westbury, NY – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced the acquisition of Valley Biomedical Products & Services, Inc. located in Winchester, VA. Founded in 1986, Valley Biomedical provides specialized biological products and services for the […]
WELLESLEY, Mass. — Ampersand Capital Partners announced today that it has completed the sale of Nexcelom Bioscience, one of its portfolio companies and a leading provider of automated cell counting solutions, to PerkinElmer for $260 million in cash. Founded in 2003 and headquartered in Lawrence, Massachusetts, Nexcelom is the manufacturer of innovative Cellometer, Cellaca MX, and Celigo image cytometry […]
● Integrated single software platform will enable true patient-centric precision oncology at scale for cancer patients care combining medical, germline, somatic and liquid biopsy data analysis together. ● Cambridge Cancer Genomics OncOS machine learning oncology software will be integrated in Dante Labs CE-IVD, ISO13485 Immensa Genomics Interpretation Software, and it will become available to clinical […]
Tecan to acquire Paramit Corporation, a leading OEM developer and manufacturer of medical devices and life sciences instruments, for a total consideration of USD 1.0 billion (CHF 920 million) In full year 2021, Paramit is expected to generate around USD 280m in sales (CHF 257m) and around USD 50m EBITDA (CHF 46m), before acquisition-related costs Transaction expected to be immediately and significantly accretive to earnings per share (EPS) upon closing Adds complementary expertise, broadens design, development and manufacturing capabilities Expansion into the attractive and fast–growing medical […]
Solutions to complement Company’s growing position in cell and gene therapy research and development WALTHAM, Mass. — PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) is pleased to announce it has entered into an agreement to acquire SIRION Biotech GmbH, a leading, global provider of viral vector-based technologies that drive improved delivery performance for cell and gene therapies. The acquisition is […]
WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into an agreement to acquire Toulouse, France based Polymem S.A. (“Polymem”), a leading industrial expert in the development and manufacture of hollow fiber membranes and modules. Tony J. Hunt, President and CEO of Repligen, […]
Saluggia – DiaSorin (FTSE MIB: DIA) announces that the Shareholders’ Meeting of Luminex Corporation (“Luminex”; NASDAQ: LMNX), held today, approved the merger of Luminex with a U.S. wholly-owned subsidiary of DiaSorin, pursuant to the merger agreement relating to the acquisition of Luminex by DiaSorin, as announced on April 11, 2021. Following the merger, Luminex shareholders […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
